---
title: "OrbiMed Advisors reports acquisition of $15 million in Aspen Neuroscience common shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/304354913.md"
description: "OrbiMed Advisors acquired $15 million in Aspen Neuroscience common shares, purchasing 1,000,000 shares at $15 each. Combined with 2,589,132 shares from preferred stock conversions, the joint filing with OrbiMed Capital GP VII reports an indirect beneficial ownership of 3,589,132 common shares following these transactions."
datetime: "2026-11-04T23:49:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/304354913.md)
  - [en](https://longbridge.com/en/news/304354913.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/304354913.md)
generator: "portal-rs"
---

# OrbiMed Advisors reports acquisition of $15 million in Aspen Neuroscience common shares

-   OrbiMed Advisors reported buying 1,000,000 Aspen Neuroscience common shares at $15 each. \* Preferred stock conversions added 2,589,132 common shares. \* The joint filing with OrbiMed Capital GP VII reported indirect beneficial ownership of 3,589,132 common shares following the transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspen Neuroscience Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000947871-26-000980), on November 04, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [ASPE.US](https://longbridge.com/en/quote/ASPE.US.md)

## Related News & Research

- [OrbiMed Advisors Discloses Investment at Aspen Neuroscience, Inc. with 12.3% Stake](https://longbridge.com/en/news/304700413.md)
- [ARCH Venture Partners X Discloses 12.9% Stake in Aspen Neuroscience](https://longbridge.com/en/news/304929595.md)
- [Aspen Neuroscience's Amended Bylaws Take Effect at IPO Closing](https://longbridge.com/en/news/304014788.md)
- [ARCH Venture Fund XIV Reports Acquisition of $18 Million in Aspen Neuroscience Common Shares](https://longbridge.com/en/news/304042044.md)
- [BUZZ-Aspen Neuroscience falls in Nasdaq debut after $141 million US IPO](https://longbridge.com/en/news/303777387.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**